Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (1-10 of 380) with videos related to

Pageof 38
Sort By:
Hematology/Oncology Clinics of North America|October 3, 2007
Autologous and allogeneic stem cell transplantation in Hodgkin's lymphomaAnna Sureda
The Lancet. Oncology|May 16, 2014
Lymphoma-directed conditioning for aggressive lymphomaAnna Sureda
Lancet (London, England)|November 16, 2024
Glofit-GemOx: a new treatment paradigm in relapsed or refractory diffuse large B-cell lymphoma?Anna Sureda, Astrid Pavlosky
Lancet (London, England)|June 19, 2022
Second-line CAR T cells for lymphomasAlberto Mussetti, Anna Sureda
The Lancet. Haematology|January 15, 2016
Mesenchymal stromal cells for steroid-refractory acute GVHDRocío Parody, Anna Sureda
Blood|April 3, 2025
Prizloncabtagene autoleucel: a new CAR T cell for B-NHLAlberto Mussetti, Anna Sureda
The Lancet. Oncology|July 6, 2023
γ-Secretase inhibitors plus anti-BCMA chimeric antigen receptor T cellsAlberto Mussetti, Anna Sureda
Bone Marrow Transplantation|August 2, 2024
Half a century of healing: celebrating the 50th anniversary of EBMTEliane Gluckman, Anna Sureda
The Lancet. Haematology|January 21, 2020
What's behind chronic graft versus host disease incidence curves?Alberto Mussetti, Anna Sureda
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
The evolving role of stem cell transplants in lymphomasEsa Jantunen, Anna Sureda
Pageof 38

Showing results (1-10 of 380) with videos related to

Sort By:
Pageof 38
Hematology/Oncology Clinics of North America|October 3, 2007
Autologous and allogeneic stem cell transplantation in Hodgkin's lymphomaAnna Sureda
The Lancet. Oncology|May 16, 2014
Lymphoma-directed conditioning for aggressive lymphomaAnna Sureda
Lancet (London, England)|November 16, 2024
Glofit-GemOx: a new treatment paradigm in relapsed or refractory diffuse large B-cell lymphoma?Anna Sureda, Astrid Pavlosky
Lancet (London, England)|June 19, 2022
Second-line CAR T cells for lymphomasAlberto Mussetti, Anna Sureda
The Lancet. Haematology|January 15, 2016
Mesenchymal stromal cells for steroid-refractory acute GVHDRocío Parody, Anna Sureda
Blood|April 3, 2025
Prizloncabtagene autoleucel: a new CAR T cell for B-NHLAlberto Mussetti, Anna Sureda
The Lancet. Oncology|July 6, 2023
γ-Secretase inhibitors plus anti-BCMA chimeric antigen receptor T cellsAlberto Mussetti, Anna Sureda
Bone Marrow Transplantation|August 2, 2024
Half a century of healing: celebrating the 50th anniversary of EBMTEliane Gluckman, Anna Sureda
The Lancet. Haematology|January 21, 2020
What's behind chronic graft versus host disease incidence curves?Alberto Mussetti, Anna Sureda
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
The evolving role of stem cell transplants in lymphomasEsa Jantunen, Anna Sureda
Pageof 38